Terms: = Ovarian cancer AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580
18 results:
1. Structural insights into ubiquitin chain cleavage by
Kang S; Kim G; Choi M; Jeong M; van der Heden van Noort GJ; Roh SH; Shin D
Life Sci Alliance; 2023 Jul; 6(7):. PubMed ID: 37100438
[TBL] [Abstract] [Full Text] [Related]
2. Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy.
Uribe-Herranz M; Beghi S; Ruella M; Parvathaneni K; Salaris S; Kostopoulos N; George SS; Pierini S; Krimitza E; Costabile F; Ghilardi G; Amelsberg KV; Lee YG; Pajarillo R; Markmann C; McGettigan-Croce B; Agarwal D; Frey N; Lacey SF; Scholler J; Gabunia K; Wu G; Chong E; Porter DL; June CH; Schuster SJ; Bhoj V; Facciabene A
Mol Ther; 2023 Mar; 31(3):686-700. PubMed ID: 36641624
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial ovarian cancer.
Han GH; Hwang I; Cho H; Ylaya K; Choi JA; Kwon H; Chung JY; Hewitt SM; Kim JH
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071938
[TBL] [Abstract] [Full Text] [Related]
4. OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
Tang J; Wu Z; Tian Z; Chen W; Wu G
Cell Death Dis; 2021 May; 12(6):534. PubMed ID: 34035221
[TBL] [Abstract] [Full Text] [Related]
5. Microcystic pattern and shadowing are independent predictors of ovarian borderline tumors and cystadenofibromas in ultrasound.
Zheng X; Lyu G; Gan Y; Hu M; Liu X; Chen S; Wu X; Yang W; Ye F; Yan X; Zhang Y
Eur Radiol; 2021 Jan; 31(1):45-54. PubMed ID: 32780208
[TBL] [Abstract] [Full Text] [Related]
6. Co-expressed functional module-related genes in ovarian cancer stem cells represent novel prognostic biomarkers in ovarian cancer.
Gov E
Syst Biol Reprod Med; 2020 Aug; 66(4):255-266. PubMed ID: 32441533
[TBL] [Abstract] [Full Text] [Related]
7. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.
Bi E; Li R; Bover LC; Li H; Su P; Ma X; Huang C; Wang Q; Liu L; Yang M; Lin Z; Qian J; Fu W; Liu YJ; Yi Q
J Clin Invest; 2018 Nov; 128(11):4821-4831. PubMed ID: 30277474
[TBL] [Abstract] [Full Text] [Related]
8. Ad5
Uusi-Kerttula H; Davies JA; Thompson JM; Wongthida P; Evgin L; Shim KG; Bradshaw A; Baker AT; Rizkallah PJ; Jones R; Hanna L; Hudson E; Vile RG; Chester JD; Parker AL
Clin Cancer Res; 2018 Sep; 24(17):4215-4224. PubMed ID: 29798908
[No Abstract] [Full Text] [Related]
9. a20 inhibits both the degradation and limited processing of the NF-κB p105 precursor: A novel additional layer to its regulator role.
Lapid D; Lahav-Baratz S; Cohen S
Biochem Biophys Res Commun; 2017 Nov; 493(1):52-57. PubMed ID: 28923245
[TBL] [Abstract] [Full Text] [Related]
10. Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies.
Uusi-Kerttula H; Davies J; Coughlan L; Hulin-Curtis S; Jones R; Hanna L; Chester JD; Parker AL
Oncotarget; 2016 May; 7(19):27926-37. PubMed ID: 27056886
[TBL] [Abstract] [Full Text] [Related]
11. Deubiquitinases and the new therapeutic opportunities offered to cancer.
Pfoh R; Lacdao IK; Saridakis V
Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
[TBL] [Abstract] [Full Text] [Related]
12. Control values of ovarian cancer tumor markers and standardisation of a protocol for sampling peritoneal fluid and performing washing during laparoscopy.
Galic Jerman K; Kobal B; Jakimovska M; Verdenik I; Cerne K
World J Surg Oncol; 2014 Sep; 12():278. PubMed ID: 25185697
[TBL] [Abstract] [Full Text] [Related]
13. Regulation of a20 and other OTU deubiquitinases by reversible oxidation.
Kulathu Y; Garcia FJ; Mevissen TE; Busch M; Arnaudo N; Carroll KS; Barford D; Komander D
Nat Commun; 2013; 4():1569. PubMed ID: 23463012
[TBL] [Abstract] [Full Text] [Related]
14. a20/tnfaip3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
[TBL] [Abstract] [Full Text] [Related]
15. a20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme.
Malynn BA; Ma A
J Exp Med; 2009 May; 206(5):977-80. PubMed ID: 19380636
[TBL] [Abstract] [Full Text] [Related]
16. Structure of the a20 OTU domain and mechanistic insights into deubiquitination.
Komander D; Barford D
Biochem J; 2008 Jan; 409(1):77-85. PubMed ID: 17961127
[TBL] [Abstract] [Full Text] [Related]
17. A novel type of deubiquitinating enzyme.
Evans PC; Smith TS; Lai MJ; Williams MG; Burke DF; Heyninck K; Kreike MM; Beyaert R; Blundell TL; Kilshaw PJ
J Biol Chem; 2003 Jun; 278(25):23180-6. PubMed ID: 12682062
[TBL] [Abstract] [Full Text] [Related]
18. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract] [Full Text] [Related]
